Glenmede Trust CO Na Guardant Health, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $107,457 - $146,124	-1,075 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $358,342 - $577,590	-5,924 Reduced 84.64%	1,075 $87,000
Q4 2019 Feb 12, 2020	BUY	$59.49 - $82.78 $54,849 - $76,323	922 Added 15.17%	6,999 $546,000
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $346,873 - $611,282	5,542 Added 1035.89%	6,077 $387,000
Q2 2019 Aug 13, 2019	BUY	$63.94 - $91.11 $21,419 - $30,521	335 Added 167.5%	535 $46,000
Q1 2019 May 14, 2019	BUY	$34.3 - $97.98 $6,859 - $19,596	200 New	200 $15,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.